Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis

Abstract excerpt

Multiple sclerosis (MS) is a chronic autoimmune disease in the central nervous system (CNS) marked by inflammation, demyelination, and axonal loss. Currently available MS medication is limited, thereby calling for a strategy to accelerate new drug discovery. One of the strategies to discover new drugs is to utilize old drugs for new indications, an approach known as drug repurposing. Herein, we first identified...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytokine Signaling Pathways and Interactions
• Share to Rheumatoid Arthritis Research and Therapies
• Share to vaccines and immunoinformatics approaches